Instituto de Medicina Tropical “Pedro Kourí”-ko ikertzaileekin lankidetzan egindako argitalpenak (18)

2021

  1. Subtype-dependent co-receptor tropism in cuban HIV-1–Infected patients: Implications for maraviroc treatment

    MEDICC Review, Vol. 23, Núm. 3, pp. 29-36

2020

  1. Immunogenicity of Intramuscular Fractional Dose of Inactivated Poliovirus Vaccine

    Journal of Infectious Diseases, Vol. 221, Núm. 6, pp. 895-901

2018

  1. Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?

    Clinical Infectious Diseases, Vol. 67, pp. S51-S56

  2. HIV-1 antiretroviral resistance in Cuba, 2009–2014

    MEDICC Review, Vol. 20, Núm. 3, pp. 15-21

  3. Molecular epidemiology and phylogenetic analysis of human papillomavirus infection in women with cervical lesions and cancer from the coastal region of Ecuador

    Revista Argentina de Microbiologia, Vol. 50, Núm. 2, pp. 136-146

2015

  1. CRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba

    EBioMedicine, Vol. 2, Núm. 3, pp. 244-254

  2. Performance of an in-house human immunodeficiency virus type 1 genotyping system for assessment of drug resistance in Cuba

    PLoS ONE, Vol. 10, Núm. 2

2014

  1. Molecular epidemiology of human papillomavirus infections in cervical samples from cuban women older than 30 years

    Journal of Lower Genital Tract Disease, Vol. 18, Núm. 3, pp. 210-217

2013

  1. Antiretroviral drug resistance in HIV-1 therapy-naive patients in Cuba

    Infection, Genetics and Evolution, Vol. 16, pp. 144-150

2012

  1. Assessment of infection with polyomaviruses BKV, JCV and SV40 in different groups of Cuban individuals

    Archives of Virology, Vol. 157, Núm. 2, pp. 315-321

  2. High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba

    Journal of Clinical Virology, Vol. 55, Núm. 4, pp. 348-355

  3. Kaposi's Sarcoma and Human Herpesvirus 8 in Cuba: Evidence of subtype B expansion

    Virology, Vol. 432, Núm. 2, pp. 361-369

  4. Normalización de un sistema de reacción en cadena de la polimerasa en tiempo real para la cuantificación de papilomavirus humano de alto riesgo oncogénico

    VacciMonitor, Vol. 21, Núm. 1, pp. 30-37

2011

  1. Role of herpesvirus as a cause of mononucleosis-like and febrile syndromes in Cuba, 2006-2009

    MEDICC Review, Vol. 13, Núm. 4, pp. 45-49

2010

  1. Diagnosis and screening for cytomegalovirus infection in pregnant women in Cuba as prognostic markers of congenital infection in newborns: 2007-2008

    Pediatric Infectious Disease Journal, Vol. 29, Núm. 12, pp. 1105-1110

  2. HCMV seroprevalence and associated risk factors in pregnant women, Havana City, 2007 to 2008

    Prenatal Diagnosis, Vol. 30, Núm. 9, pp. 888-892

  3. Kaposi's sarcoma-associated herpesvirus load in asymptomatic contacts of Cuban epidemic KS patients

    Archives of Virology, Vol. 155, Núm. 12, pp. 1971-1976

2009

  1. In vitro anti-herpetic activity of an aqueous extract from the plant Phyllanthus orbicularis

    Phytomedicine, Vol. 16, Núm. 10, pp. 960-966